ESPERITE financial results for 2014 published, metamorphosis completed, first positive forecast growth at a 36mio Revenues for 2015 ESPERITE strengthens market position of Genoma with acquisitions of exclusive technologies for fully-certified groundbreaking genetic tests Stem cell historical CryoSave's core business now profitable and improving Consolidated operations, headcount rationalization, integrated sales and marketing strategies, laboratories integration and processes automatization completed to yield enhanced performance and results Zutphen, The Netherlands - 17 March 2015 Frederic Amar, appointed ESPERITE CEO on March 2014, is implementing from the onset an aggressive reorganization and development of the company.
http://ift.tt/1O1Os8h
http://ift.tt/1O1Os8h
No comments:
Post a Comment